Pidotimod API
| Name of Product | Pidotimod API |
|---|---|
| CAS No | 121808-62-6 |
| Therapeutic use:- | Immunostimulant peptide – enhances immune response |
| Grade | IH |
| Form:- | API Powder |
| Status | Regular |
Product Overview
Pidotimod API comes under the synthetic immunostimulant belonging to the dipeptide class.
It modulates both innate and adaptive immune responses.
This is mainly done by stimulating T-lymphocyte activity, enhancing phagocytosis, and regulating cytokine production.
Pidotimod API has a favorable safety profile and proven clinical effectiveness.
Pidotimod is also widely available for the prevention and even treatment of recurrent respiratory tract infections.
Primarily indicated for children and immunocompromised patients.
Therapeutic Applications
Boosts respiratory health by reducing how often and how severely respiratory infections occur.
Enhances immune defense mechanisms.
Works as the adjunctive therapy wherein supports conventional antimicrobial and antiviral treatments.
Effective in reducing exacerbations in chronic bronchitis and COPD.
Specification Parameters
Packaging & Storage
The product is packed and stored in HDPE or fiber drums with double LDPE liners.
Additionally, a cool, dry, and well-ventilated area is recommended.
The shelf life is 24–36 months.
Why Choose Us
Manufactured under GMP-compliant facilities with strict quality control.
We ensure high purity through stringent quality control processes.
Undergo regulatory support, i.e., COA, MSDS, and DMF documentation available.